1. Home
  2. JG vs IXHL Comparison

JG vs IXHL Comparison

Compare JG & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Mobile Limited

JG

Aurora Mobile Limited

N/A

Current Price

$7.00

Market Cap

38.9M

Sector

Technology

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$3.09

Market Cap

40.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
JG
IXHL
Founded
2012
2001
Country
China
Australia
Employees
N/A
12
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
40.1M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
JG
IXHL
Price
$7.00
$3.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.6K
★ 75.3K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$0.16
52 Week High
$8.58
$6.39

Technical Indicators

Market Signals
Indicator
JG
IXHL
Relative Strength Index (RSI) 61.87 41.26
Support Level $6.25 $3.11
Resistance Level $8.32 $3.94
Average True Range (ATR) 0.30 0.14
MACD 0.03 -0.02
Stochastic Oscillator 91.89 7.84

Price Performance

Historical Comparison
JG
IXHL

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates in one segment and generates revenues from SAAS Businesses.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.

Share on Social Networks: